Ad26.cov2-s/elasomeranLack of efficacy:2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1942卷 / 1期

关键词：

D O I：

10.1007/s40278-023-32626-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：17 / 17

相关论文

共 50 条

[1] Ad26.cov2-s/elasomeranDemyelinating neuropathy: 2 case reports
Reactions Weekly, 2022, 1917 (1) : 22 - 22
[2] Ad26.cov2-s/tozinameranGuttate psoriasis: 2 case reports
Reactions Weekly, 2022, 1922 (1) : 25 - 25
[3] Ad26.cov2-s/tozinameranMyocarditis: 3 case reports
Reactions Weekly, 2022, 1918 (1) : 22 - 22
[4] Ad26.COV2-S/elasomeran/tozinameranMyocarditis: 7 case reports
Reactions Weekly, 2022, 1917 (1) : 23 - 24
[5] Ad26.cov2-s/tozinameranTransient tachycardia and pseudoseizure: 2 case reports
Reactions Weekly, 2023, 1948 (1) : 20 - 20
[6] Ad26.cov2-s/elasomeran/tozinameranAnaphylaxis: 8 case reports
Reactions Weekly, 2023, 1946 (1) : 17 - 17
[7] Ad26.COV2-S/elasomeran/tozinameranMyocarditis: 7 case reports
Reactions Weekly, 2022, 1903 (1) : 20 - 20
[8] Ad26.COV2-S/elasomeranAcute myocardial infarction and myocarditis: 2 case reports
Reactions Weekly, 2023, 1986 (1) : 19 - 19
[9] Ad26.COV2-S/tozinameranDe novo immune thrombocytopenia: 2 case reports
Reactions Weekly, 2022, 1919 (1) : 21 - 21
[10] Ad26.cov2-s/elasomeran/tozinameranEye disorders: 4 case reports
Reactions Weekly, 2022, 1933 (1) : 17 - 17

← 1 2 3 4 5 →